Benefit of Dual-chamber Pacing With Closed Loop Stimulation (CLS) in Tilt-induced Cardioinhibitory Reflex Syncope
NCT02324920 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 128
Last updated 2021-11-17
Summary
The purpose of this study is to assess whether the Closed Loop Stimulation (CLS) in addition to the DDD pacing is effective in reducing syncopal recurrences. The study hypothesis is that DDD pacing with CLS stimulation is able to prevent syncopal recurrences completely or partially by transforming syncope in pre-syncope.
Conditions
- Syncope
Interventions
- DEVICE
-
DDD-CLS
- DEVICE
-
ODO
Sponsors & Collaborators
-
Biotronik SE & Co. KG
lead INDUSTRY
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 40 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-10-31
- Primary Completion
- 2020-04-30
- Completion
- 2020-07-31
Countries
- Canada
- France
- Italy
- Netherlands
- Portugal
- Spain
Study Locations
More Related Trials
-
A Study of Norepinephrine in Patients With Congenital Insensitivity to Pain and Anhidrosis
NCT02624310 ·Status: WITHDRAWN ·Phase: PHASE2
-
Use of Accelerometer for Quantification of Neurogenic Orthostatic Hypotension Symptoms
NCT04782830 ·Status: RECRUITING ·Phase: NA
-
Long-term Study Of Ropinirole In Restless Legs Syndrome
NCT00329602 ·Status: COMPLETED ·Phase: PHASE4
-
Understanding Individual Variability in Neuronal Signal Transmission to Target Organs in Health and Disease
NCT06912048 ·Status: RECRUITING ·Phase: NA
-
Narcolepsy - New Potential Treatment
NCT02077036 ·Status: UNKNOWN ·Phase: NA
-
Riluzole in the Treatment of Spasticity in the Traumatic Chronic Spinal Cord Injury Condition
NCT02859792 ·Status: UNKNOWN ·Phase: PHASE2
-
Noninvasive Peripheral Nerve Stimulation for Medication-Naive and Medication-Refractory RLS
NCT05214963 ·Status: COMPLETED ·Phase: NA
-
Sinusoidal Galvanic Vestibular Stimulation for Neurogenic Orthostatic Hypotension / Syncope
NCT04976101 ·Status: WITHDRAWN ·Phase: NA
-
Extension Study Evaluating NTX100 Neuromodulation System for Medication-Refractory Primary RLS
NCT05196828 ·Status: COMPLETED ·Phase: NA
-
Four Different Transdermal Doses of Rotigotine in Subjects With Idiopathic Restless Legs Syndrome
NCT00135993 ·Status: COMPLETED ·Phase: PHASE3
-
Transdermal Lisuride: a Trial for the Treatment of Patients With Restless Legs Syndrome (RLS)
NCT00367822 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Laboratory Evaluation of Chronic Autonomic Failure
NCT03648905 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Examine the, Safety, Tolerability and Pharmacokinetics Co-Administered Baclofen and Memantine in Obese and Lean, Otherwise Healthy Adults
NCT02001584 ·Status: COMPLETED ·Phase: PHASE1
-
Observational Study on 2-chloroprocaine Hydrochloride 1%
NCT02067806 ·Status: COMPLETED
-
Anti-Cholinergic Receptors Antibodies, Autonomic Profile and Dysautonomia Symptoms in PAF, ALS and POTS (DISAUT-AB)
NCT04875949 ·Status: COMPLETED ·Phase: NA
-
The Safety, Tolerability and Efficacy of Dronabinol, for the Treatment of Nausea and Vomiting in Familial Dysautonomia
NCT02608931 ·Status: WITHDRAWN ·Phase: PHASE2
-
A Study of Glycopyrronium Cloth, 2.4% in Patients With Palmar Hyperhidrosis
NCT03880266 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT03750552 ·Status: COMPLETED ·Phase: PHASE3
-
Study to Evaluate Multiple Ascending Dose and Multi-Dose of DT-216 in Adult Patients With Friedreich Ataxia
NCT05573698 ·Status: COMPLETED ·Phase: PHASE1
-
Study to Evaluate the Long-Term Safety, Tolerability and Efficacy of Dalfampridine.
NCT02422940 ·Status: TERMINATED ·Phase: PHASE3
-
A Pharmacokinetics and Safety Study of BIIB132 in Adults With Spinocerebellar Ataxia 3
NCT05160558 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase 2b Study of Dalfampridine 10mg Extended Release Tablet in Subjects With Chronic Deficits After Ischemic Stroke
NCT01605825 ·Status: COMPLETED ·Phase: PHASE2
-
The Early Reversibility of Rocuronium After Different Doses of Neostigmine
NCT00001520 ·Status: COMPLETED ·Phase: PHASE4
-
Study to Determine Pharmacodynamic Effects and Pharmacokinetics of KUC 7483 CL in Patients With Spinal Cord Injury and Neurogenic Detrusor Overactivity
NCT02259751 ·Status: COMPLETED ·Phase: PHASE1
-
Effect on RLS Symptom Severity After Switching to Neupro® in Patients Who Previously Experienced Augmentation
NCT01386944 ·Status: COMPLETED